These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 6794445)

  • 1. Susceptibility of enterococci and Listeria monocytogenes to N-Formimidoyl thienamycin alone and in combination with an aminoglycoside.
    Eliopoulos GM; Moellering RC
    Antimicrob Agents Chemother; 1981 May; 19(5):789-93. PubMed ID: 6794445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergism between N-formimidoyl thienamycin and gentamicin or tobramycin against enterococci.
    Watanakunakorn C; Tisone JC
    Antimicrob Agents Chemother; 1982 Dec; 22(6):1082-3. PubMed ID: 6818900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative activity of imipenem (N-formimidoyl thienamycin) on enterococci and its interactions with aminoglycosides.
    Aznar J; García Iglesias MC; Perea EJ
    J Antimicrob Chemother; 1984 Feb; 13(2):129-32. PubMed ID: 6423613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of in vivo and in vitro bactericidal activity of N-formimidoyl thienamycin against enterococci.
    Auckenthaler R; Wilson WR; Wright AJ; Washington JA; Durack DT; Geraci JE
    Antimicrob Agents Chemother; 1982 Sep; 22(3):448-52. PubMed ID: 6958215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergy of imipenem or penicillin G and aminoglycosides against enterococci isolated from patients with infective endocarditis.
    Indrelie JA; Wilson WR; Matsumoto JY; Geraci JE; Washington JA
    Antimicrob Agents Chemother; 1984 Dec; 26(6):909-12. PubMed ID: 6596907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effect of N-formimidoyl thienamycin with gentamicin and amikacin against Streptococcus faecalis.
    Gombert ME; Berkowitz LB; Cummings MC
    Antimicrob Agents Chemother; 1983 Feb; 23(2):245-7. PubMed ID: 6404218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penicillin-tobramycin synergism against enterococci: a comparison with penicillin and gentamicin.
    Moellering RC; Wennersten C; Weinstein AJ
    Antimicrob Agents Chemother; 1973 Apr; 3(4):526-9. PubMed ID: 4208292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the antibacterial activities of N-formimidoyl thienamycin (MK0787) with those of other recently developed beta-lactam derivatives.
    Cullmann W; Opferkuch W; Stieglitz M; Werkmeister U
    Antimicrob Agents Chemother; 1982 Aug; 22(2):302-7. PubMed ID: 6821459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibilities of anaerobic bacteria to N-formimidoyl thienamycin (MK0787) and to other antibiotics.
    Kesado T; Watanabe K; Asahi Y; Isono M; Ueno K
    Antimicrob Agents Chemother; 1982 Jun; 21(6):1016-22. PubMed ID: 6956247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Species-specific resistance to antimocrobial synergism in Streptococcus faecium and Streptococcus faecalis.
    Moellering RC; Korzeniowski OM; Sande MA; Wennersten CB
    J Infect Dis; 1979 Aug; 140(2):203-8. PubMed ID: 113469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility of enterococci to trimethoprim and trimethoprim-sulfamethoxazole.
    Crider SR; Colby SD
    Antimicrob Agents Chemother; 1985 Jan; 27(1):71-5. PubMed ID: 3920958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of Streptococcus faecalis isolates with high-level resistance to multiple aminocyclitol aminoglycosides.
    Ikeda DP; Barry AL; Andersen SG
    Diagn Microbiol Infect Dis; 1984 Jun; 2(3):171-7. PubMed ID: 6430629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to six aminoglycosidic aminocyclitol antibiotics among enterococci: prevalence, evolution, and relationship to synergism with penicillin.
    Calderwood SA; Wennersten C; Moellering RC; Kunz LJ; Krogstad DJ
    Antimicrob Agents Chemother; 1977 Sep; 12(3):401-5. PubMed ID: 242911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of N-formimidoyl thienamycin (MK0787) against resistant strains of Pseudomonas aeruginosa, Staphylococcus epidermidis, Serratia marcescens, and Enterococcus spp.
    Livingston WK; Elliott AM; Cobbs CG
    Antimicrob Agents Chemother; 1981 Jan; 19(1):114-6. PubMed ID: 6787975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimal concentrations of aminoglycoside that can synergize with penicillin in enterococcal endocarditis.
    Carrizosa J; Levison ME
    Antimicrob Agents Chemother; 1981 Sep; 20(3):405-9. PubMed ID: 6795989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of N-formimidoyl thienamycin (MK0787), a crystalline derivative of thienamycin.
    Horadam VW; Smilack JD; Montgomery CL; Werringloer J
    Antimicrob Agents Chemother; 1980 Oct; 18(4):557-61. PubMed ID: 6934707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro comparison of N-formimidoyl thienamycin (MK0787) and Azlocillin with three aminoglycosides and ticarcillin against Pseudomonas aeruginosa.
    Matzkowitz AJ; Baltch AL; Smith RP; Sutphen NT; Hammer MC; Conroy JV
    Antimicrob Agents Chemother; 1982 Apr; 21(4):685-7. PubMed ID: 6805426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) against Pseudomonas aeruginosa.
    Corrado ML; Landesman SH; Cherubin CE
    Antimicrob Agents Chemother; 1980 Dec; 18(6):893-6. PubMed ID: 6263178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of the in vitro spectrum of activity of imipenem.
    Jones RN
    Am J Med; 1985 Jun; 78(6A):22-32. PubMed ID: 3890537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance of enterococci to antibiotic combinations.
    Chen HY
    J Antimicrob Chemother; 1986 Jul; 18(1):1-4. PubMed ID: 3093442
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.